HomeRCKT • NASDAQ
add
Rocket Pharmaceuticals Inc
Previous close
$4.97
Day range
$4.53 - $4.83
Year range
$2.19 - $9.35
Market cap
505.65M USD
Avg Volume
2.46M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 44.03M | -29.77% |
Net income | -42.54M | 29.49% |
Net profit margin | — | — |
Earnings per share | -0.38 | 38.68% |
EBITDA | -41.81M | 30.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 188.93M | -49.26% |
Total assets | 330.45M | -37.38% |
Total liabilities | 53.23M | -17.43% |
Total equity | 277.22M | — |
Shares outstanding | 108.57M | — |
Price to book | 1.94 | — |
Return on assets | -31.52% | — |
Return on capital | -34.36% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -42.54M | 29.49% |
Cash from operations | -34.84M | 25.78% |
Cash from investing | 36.42M | 196.18% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 1.58M | -98.38% |
Free cash flow | -19.42M | 23.56% |
About
Founded
1999
Headquarters
Website
Employees
202
